From: Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
Average duration of vaccine protection (years)
Critical infant vaccination coverage, p c (%)
1
99
2
98
5
97
10
94
20
91
50 (Lifelong)
85